Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study

2021113 citationsJournal Articlegold Open Access

Authors

Juan F. Alcalá‐Díaz · Instituto de Salud Carlos III

Laura Limia Pérez · Instituto Maimónides de Investigación Biomédica de Córdoba

Ricardo Gómez‐Huelgas · Hospital Regional Universitario de Málaga

María Dolores Martín Escalante · Hospital Costa del Sol

Begoña Cortés Rodríguez · Hospital Alto Guadalquivir

José Luis Zambrana-García · Hospital Alto Guadalquivir

Marta Entrenas Castillo

Abstract

Among patients hospitalized with COVID-19, treatment with calcifediol, compared with those not receiving calcifediol, was significantly associated with lower in-hospital mortality during the first 30 days. The observational design and sample size may limit the interpretation of these findings.

Topics & Keywords

Long-Term Effects of COVID-19 COVID-19 Clinical Research Studies Cystic Fibrosis Research Advances

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Nutrients

Volume 13, Issue 6, pp. 1760-1760

DOI: 10.3390/nu13061760

Field-Weighted Citation Impact: 11.21